A carregar...
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
BACKGROUND: Despite the availability of effective drug therapies that reduce low‐density lipoprotein (LDL)‐cholesterol (LDL‐C), cardiovascular disease (CVD) remains an important cause of mortality and morbidity. Therefore, additional LDL‐C reduction may be warranted, especially for people who are un...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2020
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094613/ https://ncbi.nlm.nih.gov/pubmed/33078867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011748.pub3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|